Kay Kitchen
Internal Medicine · Albany, GANPI 1467448647
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.2% of the total across 215 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $862 and has fallen 78.7% since, to $183 in 2025.
Across 215 payments — averaging $16.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$546
- Novo Nordisk$518
- GSK$445
- Dexcom, Inc.$354
- Pfizer$264
- Novartis$192
- plus $1K from 25 others
What the payments were for
- Food & beverage$3,41097%
- Education$1003%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 23 | $546 |
| Novo Nordisk | 34 | $518 |
| GSK | 27 | $445 |
| Dexcom, Inc. | 26 | $354 |
| Pfizer | 17 | $264 |
| Novartis | 12 | $192 |
| Amgen | 11 | $169 |
| AstraZeneca | 11 | $158 |
| AbbVie(2 entities) | 8 | $155 |
| E.r. Squibb & Sons, L.L.C. | 9 | $113 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $59 |
| Abbott | 3 | $53 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $50 |
| Nestle Healthcare Nutrition Inc. | 2 | $47 |
| Bayer | 2 | $42 |
| Sunovion Pharmaceuticals Inc. | 2 | $40 |
| Boehringer Ingelheim | 2 | $32 |
| Eisai Inc. | 2 | $30 |
| Exact Sciences | 2 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Almatica Pharma LLC | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
| Irhythm Technologies, Inc. | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Philips North America LLC | 1 | $14 |
| Inari Medical, Inc. | 1 | $13 |
| Medline Industries LP | 1 | $13 |
| Avanir Pharmaceuticals, Inc. | 1 | $13 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $11 |
| Senseonics, Incorporated | 2 | $11 |
How this compares
$3,510 in reported general payments places this provider in the 85th percentile of 3,311 internal medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 12 | $988 |
| Levothyroxine Sodium | 64 | $710 |
| Nifedipine ErNifedipine | 17 | $521 |
| Metoprolol Succinate | 41 | $514 |
| Potassium Chloride | 19 | $458 |
| Losartan Potassium | 23 | $261 |
| Amlodipine Besylate | 50 | $256 |
| Ezetimibe | 19 | $240 |
| Atorvastatin Calcium | 43 | $238 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 16 | $226 |
| Gabapentin | 18 | $215 |
| Metformin Hcl ErMetformin Hcl | 18 | $215 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 11 | $197 |
| ClopidogrelClopidogrel Bisulfate | 13 | $193 |
| Simvastatin | 24 | $192 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $19 | $2213 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,311 internal medicine providers in Georgia.
Other internal medicine in Albany
- Devell YoungAlbany$17K
- Michael GibsonSmyrna$2.2M
- Eduard FatakhovAlpharetta$376K
- Tracey HenryAtlanta$305K
- Sharon TuckettVilla Rica$265K
- Ebon BourneMarietta$242K
- Jennifer WoehlerSavannah$207K
- Julian HutchinsGreensboro$201K
- Brian PearlmanDalton$199K
- Scott ParryAtlanta$162K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.